Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1.7% | -4.8% | 2 / 3 | +10.1% | -3.47 pp | -1.10 pp | +14.9% | 0.40 | 2.89 | 134 | +10,1% | 17,7 | +1,7% | 2.89 | 2.16 | +33,8% |
| Pts | 0 | 0 | 8 | 4 | 0 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 5.600 (close price on 2026-09-08)EPS (TTM): 1.937
Financial charts
1.Revenue & growth
VND bn134Q2/26
1.Revenue & growth
VND bn134Q2/26
2.Profit & growth
VND bn17,7Q2/26
3.Profit mix (Penman)
VND bn71,1Q2/26
4.Margins & cost structure
%31.7%Q2/26
5.Returns & cash cycle
% · days12.7%Q2/26
6.Earnings quality & cash
VND bn172Q2/26
7.Asset structure
VND bn781Q2/26
8.Funding & debt health
VND bn · times781Q2/26
9.Revenue backlog
VND bn1,29Q2/26
10.Valuation
times · %2,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %536Q2/26
Adjusted EPS growth, latest quarter
1.7%
Average adjusted EPS growth, 3 quarters
-4.8%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26